The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Rapamycin inhibits vascular smooth muscle cell migration.
Open accessAbstract
Abnormal vascular smooth muscle cell (SMC) proliferation and migration contribute to the development of restenosis after percutaneous transluminal coronary angioplasty and accelerated arteriopathy after cardiac transplantation. Previously, we reported that the macrolide antibiotic rapamycin, but not the related compound FK506, inhibits both human and rat aortic SMC proliferation in vitro by inhibiting cell cycle-dependent kinases and delaying phosphorylation of retinoblastoma protein (Marx, S.O., T. Jayaraman, L.O. Go, and A.R. Marks. 1995. Circ. Res. 362:801). In the present study the effects of rapamycin on SMC migration were assayed in vitro using a modified Boyden chamber and in vivo using a porcine aortic SMC explant model. Pretreatment with rapamycin (2 ng/ml) for 48 h inhibited PDGF-induced migration (PDGF BB homodimer; 20 ng/ml) in cultured rat and human SMC (n = 10; P < 0.0001), whereas FK506 had no significant effect on migration. Rapamycin administered orally (1 mg/kg per d for 7 d) significantly inhibited porcine aortic SMC migration compared with control (n = 15; P < 0.0001). Thus, in addition to being a potent immunosuppressant and antiproliferative, rapamycin also inhibits SMC migration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,006
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Atomic Structures of the Human Immunophilin FKBP-12 Complexes with FK506 and Rapamycin
Van Duyne, G. D., Standaert, R. F., Karplus, P. A., Schreiber, S. L., & Clardy, J. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1012 · Cited by 1,189
Inhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGF
Ferns, G. A. A., Raines, E. W., Sprugel, K. H., Motani, A. S., Reidy, M. A., & Ross, R. (1991) · Science · doi:10.1126/science.1653454 · Cited by 1,065
Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M.-H., Massague, J., Crabtree, G. R., & Roberts, J. M. (1994) · Nature · doi:10.1038/372570a0 · Cited by 889
Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein
Brillantes, A.-M. B., Ondrias, K., Scott, A., Kobrinsky, E., Ondriašová, E., Moschella, M. C., Jayaraman, T., Landers, M., Ehrlich, B. E., & Marks, A. R. (1994) · Cell · doi:10.1016/0092-8674(94)90214-3 · Cited by 827
Self-citationJawien, A., Bowen-Pope, D. F., Lindner, V, Schwartz, S. M., & Clowes, A. W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115613 · Cited by 674
Rapamycin-Induced Inhibition of the 70-Kilodalton S6 Protein Kinase
Price, D. J., Grove, J. R., Calvo, V., Avruch, J., & Bierer, B. E. (1992) · Science · doi:10.1126/science.1380182 · Cited by 666
Rapamycin-FKBP Inhibits Cell Cycle Regulators of Proliferation in Vascular Smooth Muscle Cells
Marx, S. O., Jayaraman, T., Go, L. O., & Marks, A. R. (1995) · Circulation Research · doi:10.1161/01.res.76.3.412 · Cited by 599
Self-citationRapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase
Kuo, C. J., Chung, J., Fiorentino, D. F., Flanagan, W. M., Blenis, J., & Crabtree, G. R. (1992) · Nature · doi:10.1038/358070a0 · Cited by 595
Significance of quiescent smooth muscle migration in the injured rat carotid artery.
Clowes, A. W., & Schwartz, S. M. (1985) · Circulation Research · doi:10.1161/01.res.56.1.139 · Cited by 574
FK506 binding protein associated with the calcium release channel (ryanodine receptor).
Jayaraman, T., Brillantes, A. M., Timerman, A. P., Fleischer, S., Erdjument-Bromage, H., Tempst, P., & Marks, A. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50114-4 · Cited by 526
Self-citationGrotendorst, G. R., Seppä, H. E., Kleinman, H. K., & Martin, G. R. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3669 · Cited by 504
Stossel, T. P. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51454-x · Cited by 455
Regulation of chemotaxis by the platelet-derived growth factor receptor-β
Kundra, V., Escobedo, J. A., Kazlauskas, A., Kim, H. K., Rhee, S. G., Williams, L. T., & Zetter, B. R. (1994) · Nature · doi:10.1038/367474a0 · Cited by 439
Bornfeldt, K. E., Raines, E. W., Nakano, T., Graves, L. M., Krebs, E. G., & Ross, R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117081 · Cited by 409
Migration of smooth muscle and endothelial cells. Critical events in restenosis.
Casscells, W. (1992) · Circulation · doi:10.1161/01.cir.86.3.723 · Cited by 399
Cellular functions of immunophilins
Marks, A. R. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.3.631 · Cited by 367
Self-citationProbing Immunosuppressant Action with a Nonnatural Immunophilin Ligand
Bierer, B. E., Somers, P. K., Wandless, T. J., Burakoff, S. J., & Schreiber, S. L. (1990) · Science · doi:10.1126/science.1700475 · Cited by 352
Cardiac transplant atherosclerosis.
Billingham, M. E. (1987) · PubMed · Cited by 348
Significance of quiescent smooth muscle migration in the injured rat carotid artery.
WClowes, A., & MSchwartz, S. (1985) · Circulation Research · Cited by 337
Specific Interaction of Type I Receptors of the TGF-β Family with the Immunophilin FKBP-12
Wang, T., Donahoe, P. K., & Zervos, A. S. (1994) · Science · doi:10.1126/science.7518616 · Cited by 331
Pauly, R. R., Passaniti, A., Bilato, C., Monticone, R., Cheng, L., Papadopoulos, N., Gluzband, Y. A., Smith, L., Weinstein, C., & Lakatta, E. G. (1994) · Circulation Research · doi:10.1161/01.res.75.1.41 · Cited by 313
Molecular cloning and overexpression of the human FK506-binding protein FKBP
Standaert, R. F., Galat, A., Verdine, G. L., & Schreiber, S. L. (1990) · Nature · doi:10.1038/346671a0 · Cited by 312
Solution Structure of FKBP, a Rotamase Enzyme and Receptor for FK506 and Rapamycin
Michnick, S. W., Rosen, M. K., Wandless, T. J., Karplus, M., & Schreiber, S. L. (1991) · Science · doi:10.1126/science.1709301 · Cited by 301
Cameron, A. M., Steiner, J. P., Sabatini, D. M., Kaplin, A. I., Walensky, L. D., & Snyder, S. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1784 · Cited by 280
Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands.
Cardenas, M. E., Hemenway, C., Muir, R. S., Ye, R., Fiorentino, D., & Heitman, J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06940.x · Cited by 160
Taubman, M. B., Marmur, J. D., Rosenfield, C.-L., Guha, A., Nichtberger, S., & Nemerson, Y. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116234 · Cited by 151
Self-citationDiacylglycerol-Stimulated Formation of Actin Nucleation Sites at Plasma Membranes
Shariff, A., & Luna, E. J. (1992) · Science · doi:10.1126/science.1373523 · Cited by 148
Timerman, A. P., Jayaraman, T., Wiederrecht, G., Onoue, H., Marks, A. R., & Fleischer, S. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1101 · Cited by 138
Self-citationRijken, P. J., Hage, W. J., Henegouwen, P. M. P. V. B. E., Verkleiji, A. J., & Boonstra, J. (1991) · Journal of Cell Science · doi:10.1242/jcs.100.3.491 · Cited by 131
Pauly, R. R., Bilato, C., Sollott, S. J., Monticone, R. E., Kelly, P. T., Lakatta, E. G., & Crow, M. T. (1995) · Circulation · doi:10.1161/01.cir.91.4.1107 · Cited by 114
Inhibition of calcineurin by a novel FK-506-binding protein.
Sewell, T. J., Lam, E., Martin, M. M., Leszyk, J., Weidner, J. R., Calaycay, J. R., Griffin, P. R., Williams, H. R., Hung, S. H. Y., & Cryan, J. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31934-8 · Cited by 89
cDNA encoding murine FK506-binding protein (FKBP): nucleotide and deduced amino acid sequences
Nelson, P. A., Lippke, J. A., Murcko, M. A., Rosborough, S. L., & Peattie, D. A. (1991) · Gene · doi:10.1016/0378-1119(91)90617-k · Cited by 27
Hendrickson, B. A., Zhang, W., Craig, R. J., Yong-Jiu, J., Bierer, B. E., Burakoff, S. J., & DiLella, A. G. (1993) · Gene · doi:10.1016/0378-1119(93)90106-d · Cited by 15
Cited by
Pathology of Drug-Eluting Stents in Humans
Joner, M., Finn, A. V., Farb, A., Mont, E. K., Kolodgie, F. D., Ladich, E., Kutys, R., Skorija, K., Gold, H. K., & Virmani, R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.042 · Cited by 2,744
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,247
Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications
Lüscher, T. F., Steffel, J., Eberli, F. R., Joner, M., Nakazawa, G., Tanner, F. C., & Virmani, R. (2007) · Circulation · doi:10.1161/circulationaha.106.675934 · Cited by 906
Coronary stents: A materials perspective
Mani, G., Feldman, M. D., Patel, D., & Agrawal, C. M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.042 · Cited by 866
Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
Dzau, V. J., Braun-Dullaeus, R. C., & Sedding, D. G. (2002) · Nature Medicine · doi:10.1038/nm1102-1249 · Cited by 831
Metadata
- Authors
- Poon, M., Marx, S. O., Gallo, R., Badimon, J. J., Taubman, M. B., & Marks, A. R.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-11-15
- Volume
- 98
- Issue
- 10
- Pages
- 2277-2283
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2053467994
- Cited by
- 511
- References
- 39
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.